Cargando…

Strongyloides spp. and Cytomegalovirus Co-Infection in Patient Affected by Non-Hodgkin Lymphoma

To our knowledge, we have described the first case of Strongyloides/Cytomegalovirus (CMV) concomitant infection that occurred in a European country. The patient was a 76-year-old woman affected by relapsed non-Hodgkin lymphoma who presented interstitial pneumonia with a rapidly progressive worsening...

Descripción completa

Detalles Bibliográficos
Autores principales: Lupia, Tommaso, Crisà, Elena, Gaviraghi, Alberto, Rizzello, Barbara, Di Vincenzo, Alessia, Carnevale-Schianca, Fabrizio, Caravelli, Daniela, Fizzotti, Marco, Tolomeo, Francesco, Vitolo, Umberto, De Benedetto, Ilaria, Shbaklo, Nour, Cerutti, Alessandro, Fenu, Piero, Gregorc, Vanesa, Corcione, Silvia, Ghisetti, Valeria, De Rosa, Francesco Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305657/
https://www.ncbi.nlm.nih.gov/pubmed/37368749
http://dx.doi.org/10.3390/tropicalmed8060331
Descripción
Sumario:To our knowledge, we have described the first case of Strongyloides/Cytomegalovirus (CMV) concomitant infection that occurred in a European country. The patient was a 76-year-old woman affected by relapsed non-Hodgkin lymphoma who presented interstitial pneumonia with a rapidly progressive worsening of respiratory insufficiency, leading to cardiac dysfunction and consequent death. CMV reactivation is a common complication in immunocompromised patients, while hyperinfection/disseminated strongyloidiasis (HS/DS) is rare in low endemic regions, but has been widely described in Southeast Asia and American countries. HS and DS are two consequences of the failure of infection control by the immune system: HS is the uncontrolled replication of the parasite within the host and DS the spreading of the L3 larvae in organs other than the usual replication sites. Only a few cases of HS/CMV infection have been reported in the literature, and only in one patient with lymphoma as an underlying disease. The clinical manifestations of these two infections overlap, usually leading to a delayed diagnosis and a consequent poor outcome.